Long-Term Outcomes of a Randomized Study of Neoadjuvant Induction Dual HER2 Blockade with Trastuzumab and Lapatinib Followed by Weekly Paclitaxel Plus Dual HER2 Blockade for HER2-Positive Primary Breast Cancer (Neo-Lath Study).

Autor: Tokunaga, Eriko1 (AUTHOR) tokunaga.eriko.pw@mail.hosp.go.jp, Masuda, Norikazu2 (AUTHOR) nmasuda@alpha.ocn.ne.jp, Yamamoto, Naohito3 (AUTHOR) nyamamot@chiba-cc.jp, Iwata, Hiroji4 (AUTHOR) hiwata@aichi-cc.jp, Bando, Hiroko5 (AUTHOR) bando@md.tsukuba.ac.jp, Aruga, Tomoyuki6 (AUTHOR) aruga@cick.jp, Ohtani, Shoichiro7 (AUTHOR) info@ohtani-nyusen.jp, Fujisawa, Tomomi8 (AUTHOR) fujisawa@gunma-cc.jp, Takano, Toshimi9 (AUTHOR) takano@toranomon.gr.jp, Inoue, Kenichi10 (AUTHOR) ino@saitama-pho.jp, Suganuma, Nobuyasu11 (AUTHOR) suganuma@yokohama-cu.ac.jp, Takada, Masahiro12 (AUTHOR) masahiro@kuhp.kyoto-u.ac.jp, Aogi, Kenjiro13 (AUTHOR) aogi.kenjiro.zx@mail.hosp.go.jp, Sakurai, Kenichi14 (AUTHOR) sakurai.kenichi@tky.ndu.ac.jp, Shigematsu, Hideo15 (AUTHOR) shigematsu.hideo.tf@mail.hosp.go.jp, Kuroi, Katsumasa16 (AUTHOR) kurochan@tokyo-hmt.jp, Haga, Hironori17 (AUTHOR) haga@kuhp.kyoto-u.ac.jp, Ohno, Shinji18 (AUTHOR) shinji.ohno@jfcr.or.jp, Morita, Satoshi19 (AUTHOR) smorita@kuhp.kyoto-u.ac.jp, Toi, Masakazu12 (AUTHOR) toi@kuhp.kyoto-u.ac.jp
Zdroj: Cancers. Aug2021, Vol. 13 Issue 16, p4008. 1p.
Databáze: Academic Search Ultimate
Externí odkaz: